New advances in the treatment of advanced lung cancer

by Fundació Bosch i Gimpera

The University of Barcelona (UB) and Hospital Clínic de Barcelona collaborate with Boehringer Ingelheim Inc. to improve the efficiency of nintedanib, an antiangiogenic and antifibrotic drug, for the ...

Read more

Boehringer Ingelheim, new partner for the d·HEALTH Barcelona program

by Biocat

The pharma has followed the clinical immersion of the students in the Pneumology Unit at the Hospital Germans Trias i Pujol

Read more

Public-private research: the University of Barcelona (UB) and the Hospital Clínic collaborate with Boehringer Ingelheim

by Fundació Bosch i Gimpera

This study goes a step further and investigates nintedanib* effectiveness in squamous cell carcinoma, so it will use new preclinical cell crops models, unique in Spain, that allow interaction between ...

Read more
Subscribe to Directory
Write an Article

Recent News

¿Por qué no es recomendable llevar la ...

La mejor actitud que podemos adoptar es la de trat...

Exposure to Heat and Cold During Pregnan...

The research team observed changes in head circumf...

Using mobile RNAs to improve Nitrogen a...

AtCDF3 gene induced greater production of sugars a...

Highlight

Eosinófilos. ¿Qué significa tener val...

by Labo'Life

​En nuestro post hablamos sobre este interesante tipo de célula del...

Rethinking Alzheimer’s clinical trials...

by Fundació Clínic per a la Recerca Biomèdica

A paper published in Alzheimer’s & Dementia: The Journal of the Alzh...

Photos Stream